Fentanyl Citrate
Total Payments
$1.3M
Transactions
29
Doctors
7
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3,439 | 2 | 2 |
| 2023 | $501.03 | 6 | 4 |
| 2022 | $118,273 | 10 | 4 |
| 2021 | $1.2M | 11 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 14 | 98.9% |
| Consulting Fee | $12,863 | 3 | 1.0% |
| Food and Beverage | $1,124 | 12 | 0.1% |
Payments by Type
Research
$1.3M
14 transactions
General
$13,986
15 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Bedford NEMA Support | Hikma Pharmaceuticals USA | $1.3M | 0 |
Top Doctors Receiving Payments for Fentanyl Citrate
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Bonita Springs, FL | $1.3M | 14 |
| , MD | Anesthesiology | Evanston, IL | $9,854 | 5 |
| , MD | Anesthesiology | Boston, MA | $3,556 | 4 |
| , MD | Anesthesiology | Cleveland, OH | $283.95 | 2 |
| , D.O | Anesthesiology | Boston, MA | $110.49 | 1 |
| , MD | Critical Care Medicine | Evanston, IL | $110.49 | 1 |
| , C.R.N.P | Pediatrics | Philadelphia, PA | $35.63 | 1 |
| , M.D | Anesthesiology | Philadelphia, PA | $35.62 | 1 |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $1.3M
- Fresenius Kabi USA, LLC $13,986
Product Information
- Type Drug
- Total Payments $1.3M
- Total Doctors 7
- Transactions 29
About Fentanyl Citrate
Fentanyl Citrate is a drug associated with $1.3M in payments to 7 healthcare providers, recorded across 29 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2021 to 2024. In 2024, $3,439 was paid across 2 transactions to 2 doctors.
The most common payment nature for Fentanyl Citrate is "Unspecified" ($1.3M, 98.9% of total).
Fentanyl Citrate is associated with 1 research study, including "Bedford NEMA Support" ($1.3M).